Sleep and nerve pain: a pregabalin study
Treatments studied
Part of Brain & nervous system, Mental health, Pain clinical trials.
This study tests whether a nerve pain medication (pregabalin) helps people with long-term nerve pain sleep better. It involves brain scans to see how the medication affects the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had nerve pain for more than 3 months.
- Your pain has been at least moderate in the past week (4 or more on a 0–10 scale).
- You do not have severe depression or bipolar disorder.
- You are able to have an fMRI brain scan (no metal implants, pacemaker, or other metal in your body).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
This Phase 3 study tests Praga formulation to see if it safely reduces nerve pain caused by diabetes. You may qualify if you’re an adult with painful diabetic neuropathy and have certain symptom and pain scores on questionnaires.
This study is testing a treatment for chronic insomnia (trouble sleeping) in people who have long-term pain from non-cancer causes. Researchers want to see if improving sleep can help you manage your pain better.
This study tests whether pregabalin, a medication commonly used for nerve pain, can reduce chronic pelvic pain in women. It aims to see if it helps when other treatments haven't worked.
This study tests if taking Pregabalin early after a spinal cord injury can prevent pain from developing. It's a drug that may help calm nerve signals.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.